Joel E. Gallant

433 total citations
8 papers, 282 citations indexed

About

Joel E. Gallant is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Joel E. Gallant has authored 8 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Virology. Recurrent topics in Joel E. Gallant's work include HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Joel E. Gallant is often cited by papers focused on HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Joel E. Gallant collaborates with scholars based in United States and Germany. Joel E. Gallant's co-authors include Kenneth L. Cohen, Rosa E. Enriquez, Lynwood Hammers, Lucy Wilson, Richard E. Nettles, Richard D. Moore, Tara L. Kieffer, Robert F. Siliciano, Deborah Persaud and Joseph Cofrancesco and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Joel E. Gallant

7 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel E. Gallant United States	6	173	157	95	26	16	8	282
Ewa Siwak Poland	9	111 0.6×	157 1.0×	58 0.6×	38 1.5×	25 1.6×	24	372
Dubravka Salemović Serbia	10	191 1.1×	179 1.1×	145 1.5×	93 3.6×	15 0.9×	41	379
Ellen G. J. Hulskotte Netherlands	8	100 0.6×	218 1.4×	54 0.6×	7 0.3×	28 1.8×	12	309
Juan González Spain	7	223 1.3×	355 2.3×	63 0.7×	17 0.7×	12 0.8×	14	467
Margherita Bracchi United Kingdom	7	187 1.1×	98 0.6×	126 1.3×	21 0.8×	6 0.4×	25	268
Iain Tatt United Kingdom	9	256 1.5×	67 0.4×	272 2.9×	28 1.1×	21 1.3×	14	425
G. Pialoux France	9	132 0.8×	103 0.7×	76 0.8×	21 0.8×	21 1.3×	33	250
Magdalena Leszczyszyn‐Pynka Poland	10	169 1.0×	103 0.7×	161 1.7×	7 0.3×	31 1.9×	41	257
Francisco Pasquau Spain	8	136 0.8×	102 0.6×	70 0.7×	9 0.3×	7 0.4×	22	258
Bernd S. Kamps Germany	4	239 1.4×	168 1.1×	171 1.8×	11 0.4×	19 1.2×	8	374

Countries citing papers authored by Joel E. Gallant

Since Specialization

Citations

This map shows the geographic impact of Joel E. Gallant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel E. Gallant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel E. Gallant more than expected).

Fields of papers citing papers by Joel E. Gallant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel E. Gallant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel E. Gallant. The network helps show where Joel E. Gallant may publish in the future.

Co-authorship network of co-authors of Joel E. Gallant

This figure shows the co-authorship network connecting the top 25 collaborators of Joel E. Gallant. A scholar is included among the top collaborators of Joel E. Gallant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel E. Gallant. Joel E. Gallant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Gallant, Joel E., Adaora A. Adimora, James Carmichael, et al.. (2020). Essential Components of Effective HIV Care: A Policy Paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition. UNC Libraries.

Smith, Davey M., Paul A. Volberding, Donna M. Jacobsen, et al.. (2020). Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel. UNC Libraries. 12 indexed citations

Wilson, Lucy & Joel E. Gallant. (2008). The Management of Treatment‐Experienced HIV‐Infected Patients: New Drugs and Drug Combinations. Clinical Infectious Diseases. 48(2). 214–221. 22 indexed citations

Nettles, Richard E., Tara L. Kieffer, Joseph Cofrancesco, et al.. (2004). Genotypic Resistance in HIV‐1–Infected Patients with Persistently Detectable Low‐Level Viremia while Receiving Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 39(7). 1030–1037. 59 indexed citations

Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2003). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 19(1). 83–83. 6 indexed citations

Gallant, Joel E., et al.. (1995). Prophylaxis for Opportunistic Infections. Annals of Internal Medicine. 122(9). 730–731. 1 indexed citations

Gallant, Joel E., et al.. (1994). Prophylaxis for Opportunistic Infections in Patients with HIV Infection. Annals of Internal Medicine. 120(11). 932–944. 124 indexed citations

Gallant, Joel E., Rosa E. Enriquez, Kenneth L. Cohen, & Lynwood Hammers. (1988). Pneumocystis carinii thyroiditis. The American Journal of Medicine. 84(2). 303–306. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact